How to Get AndroGel in North Carolina

At a glance
- Prescription required / Schedule III controlled substance in NC
- Two morning total testosterone levels below 300 ng/dL needed for diagnosis
- MDs, DOs, NPs, and PAs can prescribe in North Carolina
- Telehealth prescribing is fully legal statewide under NC telehealth statutes
- 503A compounding pharmacies in NC are licensed to compound and ship testosterone gel
- NC Medicaid does not cover AndroGel for male hypogonadism (covers testosterone only for T2D indication)
- Most commercial plans cover with prior authorization; typical copay $30 to $75 with insurance
- Brand AndroGel 1.62% average cash price: approximately $550 to $700/month without insurance
- Generic testosterone gel 1.62% average cash price: approximately $80 to $200/month
- Standard dosing: once daily application, typically 20.25 mg to 81 mg adjusted by serum levels
Step 1: Confirm You Have a Qualifying Diagnosis
AndroGel is FDA-approved for male hypogonadism, defined by clinical symptoms plus biochemical confirmation. The Endocrine Society Clinical Practice Guideline (2018) requires two separate morning fasting serum total testosterone measurements below 300 ng/dL before initiating therapy. A single low reading is not sufficient.
Symptoms that prompt evaluation include persistent fatigue, reduced libido, erectile dysfunction, depressed mood, and loss of lean mass. The 2018 guideline specifies that testing should occur between 7:00 AM and 10:00 AM because testosterone follows a circadian pattern, peaking in early morning and declining 20% to 35% by afternoon. Illness, opioid use, and glucocorticoid therapy can suppress testosterone transiently, so the guideline recommends repeating the test after acute conditions resolve.
In North Carolina, any provider ordering labs can use Quest Diagnostics, LabCorp (headquartered in Burlington, NC, giving the state dense draw-site coverage), or hospital-based labs. A basic hypogonadism workup typically includes total testosterone, free testosterone (calculated or equilibrium dialysis), LH, FSH, prolactin, CBC, and a metabolic panel. The two-draw requirement is non-negotiable for both clinical and insurance purposes.
Step 2: Get a Prescription from a Licensed NC Provider
North Carolina law permits MDs, DOs, nurse practitioners, and physician assistants to prescribe Schedule III controlled substances, which includes testosterone gel. NPs in NC operate under a collaborative practice agreement with a physician, but this does not restrict their ability to prescribe TRT once the agreement is in place.
You have three main pathways. An in-person visit with a urologist, endocrinologist, or men's health specialist is the traditional route. Wait times for new-patient endocrinology appointments in the Triangle and Charlotte metro areas average 4 to 8 weeks, according to Merritt Hawkins physician wait-time survey data. Primary care physicians also prescribe testosterone gel routinely and often have shorter scheduling windows.
Telehealth is the second pathway. North Carolina enacted Session Law 2021-26 (HB 149), which codified telehealth parity and allows synchronous audio-video visits for prescribing. A provider licensed in NC can evaluate, diagnose, and prescribe AndroGel via telehealth as long as they establish a legitimate provider-patient relationship. Several national telehealth TRT platforms operate in NC, and HealthRX connects NC patients with board-certified clinicians who can evaluate symptoms, order labs, and prescribe testosterone gel without an in-office visit.
The third pathway involves men's health clinics, several of which operate brick-and-mortar locations in Charlotte, Raleigh, Durham, Wilmington, and Asheville with on-site phlebotomy and same-day prescribing.
Step 3: Understand AndroGel Dosing and the FDA Label
The AndroGel 1.62% FDA label specifies an initial dose of 40.5 mg (two pump actuations) applied once daily to the upper arms and shoulders. The dose may be titrated between 20.25 mg and 81 mg based on serum testosterone measured 14 days after initiation or dose adjustment.
Target trough levels fall between 300 and 1 to 000 ng/dL. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with testosterone below 275 ng/dL, demonstrated that testosterone gel raised median levels to the mid-normal range for young men and improved sexual function, physical activity, and mood over 12 months [1]. The sexual function trial within TTrials showed a mean increase of 0.58 on the Psychosexual Daily Questionnaire desire domain (P<0.001 vs placebo) [1].
Application site matters. The gel must be applied to clean, dry, intact skin on the shoulders or upper arms. It should not be applied to the abdomen or genitals. The area must be covered with clothing after the gel dries (typically 2 to 5 minutes) to prevent secondary transfer. The FDA label carries a boxed warning about secondary exposure risk to women and children through skin contact.
Insurance Coverage and Prior Authorization in North Carolina
Coverage varies sharply by payer. Most commercial insurers in NC, including Blue Cross Blue Shield of North Carolina (the state's largest insurer with approximately 3.9 million members), Aetna, Cigna, and UnitedHealthcare, cover generic testosterone gel 1.62% with prior authorization. Brand-name AndroGel 1.62% is typically placed on a non-preferred or specialty tier, driving patients toward the generic.
Prior authorization documentation generally requires:
- Two morning total testosterone levels below 300 ng/dL drawn on separate days
- Documentation of clinical symptoms (ICD-10 code E29.1 for testicular hypofunction)
- Confirmation that the patient does not have breast or prostate cancer
- A recent PSA and hematocrit on file
NC Medicaid (NC Medicaid Managed Care, operated through Healthy Blue, UnitedHealthcare Community Plan, and WellCare) does not cover testosterone gel for male hypogonadism. Coverage is restricted to specific endocrine indications, primarily type 2 diabetes-related metabolic use. This leaves Medicaid beneficiaries paying out of pocket or seeking compounded alternatives.
Medicare Part D plans in NC do cover testosterone gel with prior authorization and step therapy. Step therapy may require trial and failure of testosterone cypionate injections before approving the gel, depending on the specific Part D formulary. The AUA/Endocrine Society joint position statement on testosterone therapy recognizes topical formulations as first-line options, which can support appeals if step therapy is imposed [2].
For patients paying cash, generic testosterone gel 1.62% ranges from $80 to $200 per month at North Carolina retail pharmacies. GoodRx and manufacturer coupons can reduce this further. Brand AndroGel runs $550 to $700 without insurance.
Telehealth TRT in North Carolina: How It Works
Telehealth testosterone prescribing in NC follows a straightforward workflow. The patient schedules a video consultation with an NC-licensed provider. Before or after the visit, the provider orders bloodwork, which the patient completes at a local lab. Once two qualifying testosterone values are confirmed alongside appropriate clinical history, the provider writes the prescription electronically.
NC law requires that the prescriber be licensed by the North Carolina Medical Board (for MDs/DOs) or the NC Board of Nursing (for NPs). The Interstate Medical Licensure Compact, which North Carolina joined, allows physicians licensed through the Compact to practice telehealth across member states, expanding the pool of available prescribers.
EPCS (Electronic Prescribing for Controlled Substances) is the standard method for transmitting a testosterone gel prescription in NC. The prescription is sent directly to the patient's chosen pharmacy. Paper prescriptions for Schedule III substances are also legal in NC but increasingly uncommon.
Turnaround times vary. From first telehealth visit to gel in hand, patients typically wait 5 to 10 business days: 1 to 3 days for the visit, 2 to 4 days for lab results, and 1 to 3 days for pharmacy fulfillment. Patients with prior labs already meeting the two-draw requirement can receive a prescription as early as the same day as their telehealth evaluation.
503A Compounding Pharmacies in North Carolina
North Carolina has a strong network of 503A compounding pharmacies regulated by the NC Board of Pharmacy. These pharmacies can compound testosterone gel in custom concentrations (commonly 5%, 10%, or 20% formulations) when a prescriber writes a patient-specific prescription.
Compounded testosterone gel is not FDA-approved, but it is legal under Section 503A of the Federal Food, Drug, and Cosmetic Act when dispensed pursuant to a valid prescription. The FDA's guidance on compounding outlines the conditions under which 503A pharmacies operate, including the requirement that they compound from bulk pharmaceutical-grade ingredients and not copy commercially available products in identical concentrations [3].
Pricing for compounded testosterone gel in NC typically runs $40 to $120 per month, making it a cost-effective alternative for patients without insurance coverage or those facing high copays. Several NC-based 503A pharmacies ship statewide, meaning patients in rural areas like the Outer Banks or western mountain counties have equal access. The pharmacy must hold an active NC Board of Pharmacy license and may not ship across state lines under 503A rules unless the patient's prescriber is in the same state.
Monitoring After Starting AndroGel
The Endocrine Society guideline recommends checking serum testosterone 2 to 4 weeks after initiating gel therapy, then at 3, 6, and 12 months, and annually thereafter [2]. Hematocrit should be checked at baseline and at each follow-up visit because testosterone stimulates erythropoiesis. A hematocrit above 54% requires dose reduction or temporary discontinuation.
PSA should be measured at baseline, 3 to 6 months, and then per age-appropriate screening intervals. A PSA rise exceeding 1.4 ng/mL within 12 months warrants urological referral, per the AUA guideline on PSA testing [4].
Lipid panels and metabolic markers should be assessed annually. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found no increased incidence of major adverse cardiovascular events in men aged 45 to 80 treated with testosterone gel versus placebo over a mean follow-up of 33 months (hazard ratio 0.99; 95% CI 0.81 to 1.21) [5]. This trial resolved years of cardiovascular uncertainty around TRT and was a factor in the FDA's updated labeling.
Bone mineral density is a secondary endpoint worth tracking. The TTrials bone sub-study demonstrated that testosterone gel increased volumetric bone mineral density of the spine by 7.5% over 12 months compared to placebo, as measured by quantitative CT [1].
Transferring an Existing AndroGel Prescription to North Carolina
Patients relocating to NC can transfer an existing testosterone gel prescription from another state. NC follows the Uniform Controlled Substances Act, which permits pharmacies to accept transferred Schedule III prescriptions. The originating pharmacy and receiving NC pharmacy coordinate the transfer directly.
There are limits. A prescription can only be transferred once under DEA regulations. If the prescription has already been transferred between two pharmacies, the patient needs a new prescription from an NC-licensed provider. For patients moving to NC and establishing care with a new provider, bringing prior lab results and prescription history speeds the process considerably.
Telehealth platforms that operate in multiple states can also re-prescribe to an NC pharmacy if the prescribing clinician holds an active NC license. This eliminates the transfer restriction entirely because it constitutes a new prescription rather than a transfer.
Out-of-Pocket Cost Reduction Strategies
North Carolina patients without adequate insurance coverage have several options to reduce costs. Generic testosterone gel 1.62% is the most direct savings path: it is bioequivalent to brand AndroGel and typically 70% to 85% cheaper at retail pharmacies.
Manufacturer copay cards from AbbVie may reduce brand AndroGel costs for commercially insured patients to as low as $30 per month, though these cards do not apply to government insurance (Medicare, Medicaid, Tricare). Pharmacy discount programs through GoodRx, RxSaver, or SingleCare can bring generic gel prices to $60 to $100 at major NC chains like CVS, Walgreens, and Harris Teeter Pharmacy.
Compounded testosterone gel from an NC 503A pharmacy remains the lowest-cost option for many patients, particularly those paying entirely out of pocket. A 30-day supply of compounded testosterone gel 1% (100 mg/mL, 30 grams) typically costs $40 to $80 at NC compounding pharmacies. Patients should confirm that their compounding pharmacy participates in the PCAB (Pharmacy Compounding Accreditation Board) or holds equivalent quality certifications.
Veterans enrolled in the VA system can obtain testosterone gel through the Durham VA Medical Center, the Fayetteville VA, the Asheville VA, or any VA Community-Based Outpatient Clinic in NC at standard VA formulary copay rates ($5 to $11 for a 30-day supply).
Frequently asked questions
›How do I get an AndroGel prescription in North Carolina?
›What labs are needed before AndroGel in North Carolina?
›Are there telehealth providers in North Carolina prescribing AndroGel?
›How long until I receive AndroGel in North Carolina?
›Can I transfer an AndroGel prescription to North Carolina?
›Are 503A pharmacies in North Carolina licensed to ship testosterone gel?
›Who can prescribe AndroGel in North Carolina (MD vs NP vs PA)?
›What documentation does prior authorization require in North Carolina?
›Does North Carolina Medicaid cover AndroGel?
›What is the cash price for AndroGel in North Carolina without insurance?
›Is AndroGel a controlled substance in North Carolina?
›Can I get AndroGel at a regular pharmacy in North Carolina?
References
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013;190(2):419-426. https://pubmed.ncbi.nlm.nih.gov/23312463/
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37334136/
- AndroGel (testosterone gel) 1.62% prescribing information. AbbVie Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022309s004lbl.pdf